CY1105674T1 - Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης - Google Patents

Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης

Info

Publication number
CY1105674T1
CY1105674T1 CY20051101453T CY051101453T CY1105674T1 CY 1105674 T1 CY1105674 T1 CY 1105674T1 CY 20051101453 T CY20051101453 T CY 20051101453T CY 051101453 T CY051101453 T CY 051101453T CY 1105674 T1 CY1105674 T1 CY 1105674T1
Authority
CY
Cyprus
Prior art keywords
new crystal
crystal form
derivative
pyrrolidylthiocarbapenem derivative
crystal
Prior art date
Application number
CY20051101453T
Other languages
English (en)
Inventor
Izumi Saitoh
Masayuki Takahira
Toshio Kawakita
Yasuyuki Yoshioka
Original Assignee
Shionogi & Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18614158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1105674(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co., Ltd filed Critical Shionogi & Co., Ltd
Publication of CY1105674T1 publication Critical patent/CY1105674T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Παρέχεται ένα νέο κρύσταλλο ενός παραγώγου πυρρολιδυλο-θειοκαρβαπενέμης που έχει εξαιρετική σταθερότητα. Σύμφωνα με την παρούσα εφεύρεση παρέχεται ένα κρύσταλλο του (+)-(4R,5S,6S)-6-[(1R)-1-υδροξυαιθυλ]-4-μεθυλ-7-οξο-3[[(3S,5S)-5-(σουλφαμοϋλαμινομεθυλ)πυρρολιδιν-3-υλ]θειο]-1-αζαδικυκλο-[3.2.0]επτ-2-ενο-2-καρβοξυλικού οξέος που έχει μία εικόνα περίθλασης σε περίθλαση ακτίνων-Χ κρυσταλλικής κόνεως που κατά προτίμηση έχει κύριες κορυφές σε γωνίες περίθλασης (2Θ) = 13,04, 14,98, 15,88, 16,62, 20,62, 21,06, 22,18, 23,90, 26,08, 28,22 και 28,98 (μοίρες).
CY20051101453T 2000-03-31 2005-11-28 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης CY1105674T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000099868 2000-03-31
PCT/JP2001/002834 WO2001072750A1 (fr) 2000-03-31 2001-03-30 Nouvelle forme cristalline d'un derive de pyrrolidylthiocarbapenem

Publications (1)

Publication Number Publication Date
CY1105674T1 true CY1105674T1 (el) 2010-07-28

Family

ID=18614158

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20051101453T CY1105674T1 (el) 2000-03-31 2005-11-28 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
CY200900001C CY2009001I2 (el) 2000-03-31 2009-01-23 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY200900001C CY2009001I2 (el) 2000-03-31 2009-01-23 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης

Country Status (17)

Country Link
US (5) US20030153191A1 (el)
EP (1) EP1270575B1 (el)
JP (1) JP3375084B2 (el)
KR (1) KR100472842B1 (el)
CN (1) CN1192030C (el)
AT (1) ATE304014T1 (el)
AU (2) AU2001244692B2 (el)
BR (1) BRPI0109712B8 (el)
CA (1) CA2404703C (el)
CY (2) CY1105674T1 (el)
DE (1) DE60113243T2 (el)
DK (1) DK1270575T3 (el)
ES (1) ES2252205T3 (el)
MX (1) MXPA02009592A (el)
TW (1) TWI293631B (el)
WO (1) WO2001072750A1 (el)
ZA (1) ZA200207675B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1270575B1 (en) * 2000-03-31 2005-09-07 Shionogi & Co., Ltd. Novel crystal form of pyrrolidylthiocarbapenem derivative
JP5004355B2 (ja) * 2001-05-10 2012-08-22 塩野義製薬株式会社 アセチルチオピロリジン誘導体の製法
JP2005509037A (ja) * 2001-11-16 2005-04-07 ランバクシー ラボラトリーズ リミテッド 結晶イミペネム製造方法
TWI353855B (en) * 2005-05-26 2011-12-11 Shionogi & Co Method for preparing an aqueous solution of doripe
WO2007125788A1 (ja) * 2006-04-28 2007-11-08 Kaneka Corporation カルバペネム抗生物質中間体の改良された晶析方法
WO2008006298A1 (fr) * 2006-07-03 2008-01-17 Chengdu Di'ao Jiuhong Pharmaceutical Factory Nouvelle forme cristalline de doripenem, préparation, procédé et utilisations de celle-ci
CN101191787B (zh) * 2006-11-21 2011-07-27 上海医药工业研究院 高效液相色谱法测定多利培南含量的方法
PL2276762T3 (pl) * 2008-03-24 2015-06-30 Ranbaxy Laboratories Ltd Sposób wytwarzania jałowego doripenemu
WO2011150679A1 (zh) * 2010-06-03 2011-12-08 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
CN102977101A (zh) * 2011-09-07 2013-03-20 中国人民解放军军事医学科学院毒物药物研究所 多尼培南一水合物、其药物组合物、其制备方法和用途
CN102285988B (zh) * 2011-09-08 2012-09-05 上海希迈医药科技有限公司 一种多尼培南水合物晶体及其制备方法
EP2776440A1 (en) * 2011-11-08 2014-09-17 Ranbaxy Laboratories Limited Process for the preparation of polymorphs of doripenem
CN104072497B (zh) * 2013-03-29 2017-10-03 石药集团中奇制药技术（石家庄）有限公司 一种多尼培南新结晶及其制备方法
CN103389347B (zh) * 2013-07-26 2015-12-09 深圳市海滨制药有限公司 高效液相色谱法测定多尼培南的方法
KR101910048B1 (ko) 2014-04-28 2018-10-22 제이더블유중외제약 주식회사 도리페넴의 신규한 결정 및 이의 제조방법
KR20160007679A (ko) 2016-01-04 2016-01-20 제일약품주식회사 도리페넴의 신규한 결정형

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5539102A (en) * 1992-02-21 1996-07-23 Shionogi Seiyaku Kabushiki Kaisha Production method for sulfamide
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3558684B2 (ja) * 1994-06-28 2004-08-25 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の乾燥方法
EP1270575B1 (en) * 2000-03-31 2005-09-07 Shionogi & Co., Ltd. Novel crystal form of pyrrolidylthiocarbapenem derivative
WO2004072073A1 (ja) * 2003-02-14 2004-08-26 Shionogi & Co., Ltd. カルバペネム合成中間体の結晶
WO2010097686A1 (en) 2009-02-26 2010-09-02 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of carbapenem antibiotic

Also Published As

Publication number Publication date
AU4469201A (en) 2001-10-08
DE60113243D1 (de) 2005-10-13
US8247402B2 (en) 2012-08-21
JP3375084B2 (ja) 2003-02-10
US20150031664A1 (en) 2015-01-29
KR20020087446A (ko) 2002-11-22
US20080207586A1 (en) 2008-08-28
CY2009001I1 (el) 2009-11-04
AU2001244692B2 (en) 2004-10-14
KR100472842B1 (ko) 2005-03-10
BRPI0109712B8 (pt) 2021-05-25
CN1192030C (zh) 2005-03-09
DK1270575T3 (da) 2006-01-16
US20030153191A1 (en) 2003-08-14
ZA200207675B (en) 2003-09-25
US9221823B2 (en) 2015-12-29
ATE304014T1 (de) 2005-09-15
CN1432016A (zh) 2003-07-23
TWI293631B (el) 2008-02-21
EP1270575B1 (en) 2005-09-07
CY2009001I2 (el) 2009-11-04
EP1270575A4 (en) 2004-02-18
DE60113243T2 (de) 2006-02-16
MXPA02009592A (es) 2003-03-12
BR0109712A (pt) 2003-04-29
CA2404703A1 (en) 2002-09-26
US20130059831A1 (en) 2013-03-07
US20070060562A1 (en) 2007-03-15
BRPI0109712B1 (pt) 2017-10-24
WO2001072750A1 (fr) 2001-10-04
CA2404703C (en) 2007-06-05
ES2252205T3 (es) 2006-05-16
EP1270575A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
CY1105674T1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
HU9600834D0 (en) Quinazoline derivatives
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
AU6409994A (en) Organic tissue glue for closure of wounds
MX9709416A (es) Compuesto tipo quinolizinona.
AU6530896A (en) Pyrrolidine derivatives having phospholipase a2 inhibitory activity
CY2529B1 (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU7862794A (en) 2,3-diaminopropionic acid derivative
ES2121585T3 (es) Compuestos antibioticos de carbapenem.
AU2002245005A1 (en) Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
PT1334105E (pt) Preparacao de n-formimidoil-tienamicina mono-hidrata cristalina ( (imipenem mono-hidratado)
PT98773A (pt) Processo para a preparacao de di-hidropirido/4,3-d/pirimidinas substituidas na posicao 4 e de composicoes farmaceuticas analgesicas e antiinflamatorias que as contem
EP0987255A3 (en) Substituted aminoquinazolinone (thione) derivatives
TR199801835A2 (xx) Antimikrobiyal kompozisyonlar.
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
ES2121058T3 (es) Compuestos antibioticos de carbapenem.
EP0381114A3 (en) Exo-3',4'-0-benzylidene-3"-demethylchartreusin and its salts
EP1251133A4 (en) NEW CARBAPENEM DERIVATIVES
EP1023062A4 (en) ANTIBACTERIAL CARBAPENEMAS, COMPOSITIONS AND METHODS OF TREATMENT
DE69410159T2 (de) Neue Verbindung, Leustroducsin H, ihre Herstellung und therapeutische Verwendung